查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球醫用合成橡膠市場：按類型、按應用、按最終用途行業、按地區 - 預測（至 2029 年）
市場調查報告書
商品編碼
1617388

全球醫用合成橡膠市場：按類型、按應用、按最終用途行業、按地區 - 預測（至 2029 年）

Medical Elastomer Market by Type (Thermoset Elastomers; Thermoplastic Elastomers), Applications (Medical Tubing; Catheters; Syringes; Gloves; Medical & Infusion Bags and Implants), End-use Industry & Region - Global Forecast to 2029
出版日期: | 出版商: MarketsandMarkets | 英文 333 Pages | 訂單完成後即時交付

價格

全球醫用合成橡膠市場規模預計將從2024年的95.7億美元增加到2029年的142.7億美元，複合年成長率為8.3%。

對醫療設備不斷成長的需求正在推動全球對醫用合成橡膠的需求。這是因為它們擴大用於一次性醫療設備（例如注射器、瓣膜和管子）以及關鍵植入（例如人造心臟瓣膜和人造關節）。這些材料耐用、生物相容且柔韌，適合廣泛的醫療應用，包括醫用管材、袋子和手套。開發中國家不斷上漲的醫療保健成本和技術進步預計將進​​一步推動對這些關鍵產品的需求增加，使它們對於滿足世界各地不斷成長的醫療保健需求變得更加重要。此外，新興經濟體的人口成長和慢性病的流行正在創造對醫用合成橡膠的需求。

調查範圍
調查年份 2020-2029
基準年 2023年
預測期 2024-2029
單元 千噸、百萬美元
部分 類型、技術、應用、最終用途產業
目標區域 亞太地區、北美、歐洲、中東/非洲、南美

“按應用來看，植入將成為預測期內醫用合成橡膠市場以金額為準成長最快的應用。”

由於醫療手術中對生物相容性、耐用性和軟性材料的需求不斷增加，植入是醫用合成橡膠成長最快的應用。慢性病的流行和人口老化推動了對耐用醫用合成橡膠植入的需求，這些植入物為整形外科、牙科和軟組織植入提供卓越的性能。靈活性、舒適性和更少的併發症使植入更具吸引力。此外，合成橡膠可以模製成複雜的形狀，並且具有高度的生物相容性，這可能導致未來在客製化植入中的使用，進一步增加對醫用合成橡膠的需求。

“按最終用途行業來看，在預測期內，醫院和診所在醫用合成橡膠市場的以金額為準中佔據最大佔有率。”

醫院和診所由於高度依賴使用合成橡膠材料的醫療器材與設備，因此佔據了醫用合成橡膠市場的最大佔有率。這些醫療機構需要各種醫用合成橡膠產品，包括導管、醫用管材、密封件、墊圈、手術手套和植入，以確保患者得到適當的治療和護理。同時，人口老化加劇以及糖尿病、心血管疾病、呼吸系統疾病等慢性病的流行，對醫療服務的需求不斷增加，進一步推動了對這些醫療設備的需求。醫用合成橡膠具有生物相容性、優異的柔韌性、耐用性和耐化學性等特性，使其在醫院和診所的各種應用中具有強大的功能。這些因素，加上 FDA 等醫療機構的嚴格監管要求，正在推動醫院和診所採用高品質的合成橡膠產品。這些因素，加上強勁的醫療需求、遵守法規要求以及向先進可靠的醫療設備的發展，使得醫院和診所在醫療合成橡膠市場中擁有最大的行業市場佔有率。

“按地區分類，按以金額為準計算，亞太地區是醫用合成橡膠的第二大市場。”

由於經濟發展、人口快速成長、醫療產業優秀、醫療設備需求不斷增加等多種因素，亞太地區佔據醫用合成橡膠市場第二大市場規模。中國和印度等新興經濟體不斷增加的醫療基礎設施投資正在推動醫療設備（如醫用管材、植入和診斷設備）採用高品質醫用合成橡膠的需求。該地區人口眾多且老化加劇了慢性病的盛行率，刺激了這項需求。因此，亞太地區被定位為全球醫用合成橡膠市場的關鍵區域，專注於改善醫療保健服務的醫療機構組織的產品不斷成長。

本報告研究和分析了全球醫用合成橡膠市場，提供了關鍵促進因素和限制因素、競爭格局和未來趨勢的資訊。

目錄

第1章簡介

第2章調查方法

第3章執行摘要

第 4 章重要考察

  • 醫用合成橡膠市場對公司有吸引力的機會
  • 醫用合成橡膠市場：依類型（2024/2029）
  • 醫用合成橡膠市場：依應用分類（2024/2029）
  • 醫用合成橡膠市場：依最終用途產業分類（2024/2029）
  • 醫用合成橡膠市場：依主要國家分類

第5章市場概況

  • 介紹
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會
    • 任務
  • 波特五力分析
  • 主要相關利益者和採購標準
  • 宏觀經濟展望
  • 人工智慧/產生人工智慧的影響
  • 價值鏈分析
  • 生態系分析
  • 案例研究分析
  • 監管環境
    • 環境法規
    • 北美洲
    • 亞太地區
    • 歐洲
    • 監管機構、政府機構和其他組織
  • 技術分析
    • 主要技術
    • 互補技術
    • 鄰近技術
  • 影響客戶業務的趨勢/干擾
  • 貿易分析
    • 進口場景（HS編碼391000）
    • 出口場景（HS編碼391000）
    • 進口場景（HS編碼400270）
    • 出口情境（HS編碼400270）
  • 重大會議和活動（2024-2025）
  • 價格分析
    • 醫用合成橡膠體平均售價趨勢：按地區
    • 醫用合成橡膠體平均售價趨勢：依應用分類
    • 醫用合成橡膠平均銷售價格趨勢：依最終用途產業
  • 投資金籌措場景
  • 專利分析
    • 介紹
    • 專利的法律地位
    • 管轄權分析
  • 潛在客戶名單

第6章醫用合成橡膠市場：依技術分類

  • 介紹
  • 擠出成型
  • 射出成型
  • 壓縮成型
  • 其他技術

第7章醫用合成橡膠市場：依最終用途產業

  • 介紹
  • 醫院/診所
  • 製藥
  • 醫療設備製造
  • 其他最終用途產業

第8章醫用合成橡膠市場：依應用分類

  • 介紹
  • 醫用管
  • 導管
  • 手套
  • 注射器
    • 預填充式注射器
    • 非預填充式注射器
    • 管瓶
  • 醫用/輸液袋
  • 植入
  • 其他用途

第9章醫用合成橡膠市場：依類型

  • 介紹
  • 熱固性合成橡膠
    • 矽
    • 三元乙丙橡膠
    • 其他熱固性合成橡膠
  • 熱可塑性橡膠
    • 熱塑性聚氨酯
    • 苯乙烯嵌段共聚物
    • 其他熱可塑性橡膠

第10章醫用合成橡膠市場：按地區

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 印尼
    • 其他亞太地區
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 中東/非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東/非洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區

第11章競爭格局

  • 概述
  • 主要參與企業的策略/優勢（2019-2024）
  • 收益分析（2021-2023）
  • 市場佔有率分析（2023）
    • 北美市場佔有率分析：依應用分類（2023 年）
    • 歐洲市場佔有率分析：依應用分類（2023）
    • 亞太地區市場佔有率分析：按應用分類（2023 年）
    • DOW
    • EXXON MOBIL CORPORATION
    • CELANESE CORPORATION
    • BASF
    • WACKER CHEMIE AG
  • 公司評價及財務指標
  • 品牌/產品比較
    • 醫用合成橡膠市場：品牌/產品比較分析
    • ELASTOLLAN
    • ENGAGE 8480K HEALTH+
    • HYTREL
    • ECDEL
  • 企業評價矩陣：主要企業（2023年）
  • 公司評估矩陣：Start-Ups/中小企業（2023）
  • 競爭場景

第12章 公司簡介

  • 主要企業
    • DOW
    • EXXON MOBIL CORPORATION
    • CELANESE CORPORATION
    • BASF
    • WACKER CHEMIE AG
    • EASTMAN CHEMICAL COMPANY
    • SYENSQO
    • KURARAY CO., LTD
    • MITSUBISHI CHEMICAL GROUP CORPORATION
    • MOMENTIVE PERFORMANCE MATERIALS
    • ENVALIOR
    • ZEON CORPORATION
    • THE LUBRIZOL CORPORATION
  • 其他公司
    • KRATON CORPORATION
    • FOSTER CORPORATION
    • BIOMERICS
    • RTP COMPANY
    • ROMAR ENGINEERING
    • THE RUBBER GROUP
    • KENT ELASTOMER PRODUCTS
    • RAUMEDIC AG
    • THE HYGENIC COMPANY, LLC
    • HEXAPOL AB
    • TEKNI-PLEX, INC
    • TRINSEO
    • TRELLEBORG AB
    • SAINT-GOBAIN

第13章附錄

Product Code: CH 6288

The medical elastomer market is projected to reach USD 14.27 billion by 2029 from USD 9.57 billion in 2024, at a CAGR of 8.3%. Growing demand for medical devices is fueling the demand for medical elastomers worldwide. This is a result of the increased use in disposable medical equipment, such as syringes, valves, tubing, and critical implants; artificial heart valves and artificial joints. These materials are versatile, offering durability, biocompatibility, and flexibility, making them suitable in a wide range of medical applications, such as medical tubes, bags, and gloves. The growing healthcare costs in developing economies coupled with technology advancements will further fuel the increasing demand for these critical commodities, rendering them even more indispensable to meet growing healthcare needs across the world. Additionally, the expanding population in emerging economies along with the rising prevalence of chronic diseases is creating a demand for medical elastomers.

Scope of the Report
Years Considered for the Study2020-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredKiloton; Value (USD Million)
SegmentsType, Technology, Application, and End-use Industry
Regions coveredAsia Pacific, North America, Europe, Middle East & Africa, and South America

"Based on application, implants are the fastest growing application in medical elastomer market during the forecast period, in terms of value."

Implants are the fastest growing application of medical elastomers due to increasing demand for biocompatible, durable and flexible materials in medical procedures. The rising prevalence of chronic diseases and aging populations are driving the need of durable implants in medical elastomers, as it provides superior orthopedic, dental, and soft tissue implant performance. Flexibility and comfort with least complications further make them appealing. Moreover, the ability of elastomers to be molded into complex shapes and the excellent biocompatibility enhances the future applications of customized implants, thereby further fueling the demand for medical elastomers.

"Based on end-use industry, hospitals & clinics account the largest share in medical elastomer market during the forecast period, in terms of value."

Hospitals and clinics account for the largest share in the medical elastomer market due to their heavy dependence on medical devices and equipment that utilize elastomer materials. These institutions need a wide range of products based on medical elastomers such as catheters, medical tubing, seals, gaskets, surgical gloves, and implants, in order to ensure appropriate patient care and treatment. However, the growing need for healthcare services due to growing ageing population and rising prevalence of chronic diseases such as diabetes, cardiovascular diseases, and respiratory disorders further boosts the demand for these medical devices. The properties of medical elastomers such as biocompatibility and excellent flexibility & durability along with chemical resistance makes them highly functional for various applications in hospital and clinic applications. These factors, along with the stringent regulatory requirements from healthcare authorities like FDA, ensure that hospitals and clinics are adopting high-quality elastomer-based products. All these factors combined strong healthcare needs, adherence to regulatory requirements, and the drive for advanced, reliable medical devices ensure make hospitals & clinics account largest market share by industry in the medical elastomer market.

"Based on region, Asia Pacific accounts the second largest market for medical elastomer, in terms of value."

Asia Pacific accounts the second largest market for medical elastomers because of various factors such as economic development, rapid population growth, a good healthcare sector, and increasing demand for medical devices. The rise in investments for healthcare infrastructure in emerging economies like China and India is driving the demand for adoption high-quality medical elastomers into healthcare equipments such as medical tubing, implants, and diagnostic equipment. Large and aging population in the region have added up to this demand as prevalence of chronic diseases is rising among this population. Asia Pacific is, therefore, a growth product concerning medical facility organizations dedicated to better healthcare access, positioning it as a major player in the global medical elastomer market.

In the process of determining and verifying the market size for several segments and subsegments identified through secondary research, extensive primary interviews were conducted. A breakdown of the profiles of the primary interviewees are as follows:

  • By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
  • By Designation: Directors- 35%, Managers - 25%, and Others - 40%
  • By Region: North America - 22%, Europe - 22%, Asia Pacific - 45%, RoW - 11%

The key players in this market are BASF (Germany), Dow (US), Celanese Corporation (US), Eastman Chemical Company (US), Syensqo (Belgium), Mitsubishi Chemical Group Corporation (Japan), Kuraray Co., Ltd. (Japan), ExxonMobil (US), Momentive Performance Materials (US), Envalior (Germany) and Zeon Corporation (Japan).

Research Coverage

This report segments the medical elastomer market based on type, technology, application, end-use industry, and region, and provides estimations for the overall value of the market across various regions. A detailed analysis of key industry players has been conducted to provide insights into their business overviews, products and services, key strategies, new product launches, expansions, and mergers and acquisitions associated with the medical elastomer market.

Key benefits of buying this report

This research report focuses on various levels of analysis, including industry analysis (industry trends), market ranking analysis of top players, and company profiles, which together provide an overall view of the competitive landscape, emerging and high-growth segments of the medical elastomer market, high-growth regions, and market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

  • Analysis of key drivers (Growing demand for medical devices, Technological advancements in healthcare and Prevalence of chronic diseases), restraints (High production costs), opportunities (Growing healthcare investment in emerging economies) and challenges (Stringent regulatory requirements).
  • Market Penetration: Comprehensive information on the medical elastomer market offered by top players in the global medical elastomer market.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the medical elastomer market.
  • Market Development: Comprehensive information about lucrative emerging markets - the report analyzes the markets for medical elastomer market across regions.
  • Market Diversification: Exhaustive information about new products, untapped regions, and recent developments in the global medical elastomer market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of leading players in the medical elastomer market

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
    • 1.3.2 INCLUSIONS AND EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 UNITS CONSIDERED
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 List of key secondary sources
      • 2.1.1.2 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 List of key primary interview participants
      • 2.1.2.3 Key industry insights
      • 2.1.2.4 Breakdown of interviews with experts
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 BOTTOM-UP APPROACH
    • 2.2.2 TOP-DOWN APPROACH
  • 2.3 GROWTH FORECAST
  • 2.4 DATA TRIANGULATION
  • 2.5 FACTOR ANALYSIS
  • 2.6 RESEARCH ASSUMPTIONS
  • 2.7 RESEARCH LIMITATIONS AND RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN MEDICAL ELASTOMERS MARKET
  • 4.2 MEDICAL ELASTOMERS MARKET, BY TYPE, 2024 VS. 2029 (KILOTON)
  • 4.3 MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024 VS. 2029 (KILOTON)
  • 4.4 MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2024 VS. 2029 (KILOTON)
  • 4.5 MEDICAL ELASTOMERS MARKET, BY KEY COUNTRY

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing demand for medical devices
      • 5.2.1.2 Technological advancements in healthcare
      • 5.2.1.3 Prevalence of chronic diseases
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High production costs
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growing healthcare investments in emerging economies
      • 5.2.3.2 Increasing use in minimally invasive devices
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Stringent regulatory requirements
  • 5.3 PORTER'S FIVE FORCES ANALYSIS
    • 5.3.1 THREAT FROM NEW ENTRANTS
    • 5.3.2 THREAT OF SUBSTITUTES
    • 5.3.3 BARGAINING POWER OF SUPPLIERS
    • 5.3.4 BARGAINING POWER OF BUYERS
    • 5.3.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.4 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.4.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.4.2 BUYING CRITERIA
  • 5.5 MACROECONOMIC OUTLOOK
    • 5.5.1 GDP TRENDS AND FORECASTS
  • 5.6 IMPACT OF AI/GENAI
  • 5.7 VALUE CHAIN ANALYSIS
  • 5.8 ECOSYSTEM ANALYSIS
  • 5.9 CASE STUDY ANALYSIS
    • 5.9.1 KENT ELASTOMERS HELPED IN TRANSITIONING TO NON-LATEX MEDICAL COMPONENTS
    • 5.9.2 COOPER UNIVERSITY HOSPITAL BOOSTS POLYPHENYLENE ETHER RESILIENCE WITH DENTEC SAFETY COMFORT-AIRNXMD
    • 5.9.3 TECNOFLON FKM AS HIGH-PERFORMANCE ALTERNATIVE TO SILICONE IN ORTHOPEDIC APPLICATIONS
  • 5.10 REGULATORY LANDSCAPE
    • 5.10.1 ENVIRONMENTAL REGULATIONS
    • 5.10.2 NORTH AMERICA
    • 5.10.3 ASIA PACIFIC
    • 5.10.4 EUROPE
    • 5.10.5 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.11 TECHNOLOGY ANALYSIS
    • 5.11.1 KEY TECHNOLOGIES
      • 5.11.1.1 Extrusion technology
      • 5.11.1.2 Compression molding
    • 5.11.2 COMPLEMENTARY TECHNOLOGIES
      • 5.11.2.1 Co-extrusion technology
    • 5.11.3 ADJACENT TECHNOLOGIES
      • 5.11.3.1 Additive manufacturing technology
  • 5.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.13 TRADE ANALYSIS
    • 5.13.1 IMPORT SCENARIO (HS CODE 391000)
    • 5.13.2 EXPORT SCENARIO (HS CODE 391000)
    • 5.13.3 IMPORT SCENARIO (HS CODE 400270)
    • 5.13.4 EXPORT SCENARIO (HS CODE 400270)
  • 5.14 KEY CONFERENCES AND EVENTS, 2024-2025
  • 5.15 PRICING ANALYSIS
    • 5.15.1 AVERAGE SELLING PRICE TREND OF MEDICAL ELASTOMERS, BY REGION
    • 5.15.2 AVERAGE SELLING PRICE TREND OF MEDICAL ELASTOMERS, BY APPLICATION
    • 5.15.3 AVERAGE SELLING PRICE TREND OF MEDICAL ELASTOMERS, BY END-USE INDUSTRY
  • 5.16 INVESTMENT AND FUNDING SCENARIO
  • 5.17 PATENT ANALYSIS
    • 5.17.1 INTRODUCTION
    • 5.17.2 LEGAL STATUS OF PATENTS
    • 5.17.3 JURISDICTION ANALYSIS
  • 5.18 LIST OF POTENTIAL CUSTOMERS

6 MEDICAL ELASTOMERS MARKET, BY TECHNOLOGY

  • 6.1 INTRODUCTION
  • 6.2 EXTRUSION
  • 6.3 INJECTION MOLDING
  • 6.4 COMPRESSION MOLDING
  • 6.5 OTHER TECHNOLOGIES

7 MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY

  • 7.1 INTRODUCTION
  • 7.2 HOSPITALS & CLINICS
    • 7.2.1 RISING PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET
  • 7.3 PHARMACEUTICAL
    • 7.3.1 CRUCIAL ROLE OF ELASTOMERS IN PACKAGING AND DRUG DELIVERY SYSTEMS TO PROPEL ADOPTION
  • 7.4 MEDICAL DEVICE MANUFACTURING
    • 7.4.1 RISING DEMAND FOR ADVANCED MEDICAL DEVICES TO SUPPORT MARKET GROWTH
  • 7.5 OTHER END-USE INDUSTRIES

8 MEDICAL ELASTOMERS MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
  • 8.2 MEDICAL TUBING
    • 8.2.1 HIGH CONSUMPTION IN ADVANCING MEDICAL TUBING SOLUTIONS TO DRIVE MARKET
  • 8.3 CATHETERS
    • 8.3.1 VITAL ROLE IN PRODUCTION OF CATHETERS TO PROPEL GROWTH
  • 8.4 GLOVES
    • 8.4.1 INCREASING NEED FOR PERSONAL PROTECTIVE EQUIPMENT TO INCREASE DEMAND
  • 8.5 SYRINGES
    • 8.5.1 PRE-FILLED SYRINGES
      • 8.5.1.1 Reduce risk of dosing errors-key factor driving adoption
    • 8.5.2 NON-PRE-FILLED SYRINGES
      • 8.5.2.1 Increasing incidence of chronic diseases to propel adoption
    • 8.5.3 VIALS
      • 8.5.3.1 Increasing need for safe and effective drug delivery systems to drive market
  • 8.6 MEDICAL & INFUSION BAGS
    • 8.6.1 RISE IN HOSPITAL-ACQUIRED INFECTIONS TO SUPPORT MARKET GROWTH
  • 8.7 IMPLANTS
    • 8.7.1 INCREASING PREVALENCE OF AGE-RELATED HEALTH CONDITIONS TO DRIVE MARKET
  • 8.8 OTHER APPLICATIONS

9 MEDICAL ELASTOMERS MARKET, BY TYPE

  • 9.1 INTRODUCTION
  • 9.2 THERMOSET ELASTOMERS
    • 9.2.1 SILICONE
      • 9.2.1.1 Efficient alternative to latex products in medical and pharmaceutical applications
      • 9.2.1.2 High temperature vulcanized
      • 9.2.1.3 Liquid silicone rubber
      • 9.2.1.4 Room temperature vulcanized
    • 9.2.2 ETHYLENE PROPYLENE DIENE MONOMER
      • 9.2.2.1 Suitable for various medical applications-key factor supporting market growth
    • 9.2.3 OTHER THERMOSET ELASTOMERS
  • 9.3 THERMOPLASTIC ELASTOMERS
    • 9.3.1 THERMOPLASTIC POLYURETHANE
      • 9.3.1.1 Provide efficiency in manufacturing complex designs using extrusion and molding techniques
    • 9.3.2 STYRENE BLOCK COPOLYMERS
      • 9.3.2.1 Biostability of SBC increases utility in medical applications-key factor driving market growth
    • 9.3.3 OTHER THERMOPLASTIC ELASTOMERS

10 MEDICAL ELASTOMERS MARKET, BY REGION

  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    • 10.2.1 US
      • 10.2.1.1 Rising healthcare spending to drive market
    • 10.2.2 CANADA
      • 10.2.2.1 Expanding healthcare system to support market growth
    • 10.2.3 MEXICO
      • 10.2.3.1 Government initiatives and growth of healthcare sector to drive market
  • 10.3 ASIA PACIFIC
    • 10.3.1 CHINA
      • 10.3.1.1 Growing aging population to drive market
    • 10.3.2 JAPAN
      • 10.3.2.1 Increased focus on infection control and patient safety to propel market
    • 10.3.3 INDIA
      • 10.3.3.1 Increasing investments in healthcare sector to drive market
    • 10.3.4 SOUTH KOREA
      • 10.3.4.1 Rising demand for high quality medical devices to drive market
    • 10.3.5 INDONESIA
      • 10.3.5.1 Rising incidence of chronic diseases to drive market
    • 10.3.6 REST OF ASIA PACIFIC
  • 10.4 EUROPE
    • 10.4.1 GERMANY
      • 10.4.1.1 Increased investments in R&D to drive market
    • 10.4.2 UK
      • 10.4.2.1 Rising geriatric population to support market growth
    • 10.4.3 FRANCE
      • 10.4.3.1 Presence of significant medical device manufacturers to propel market
    • 10.4.4 ITALY
      • 10.4.4.1 Rising demand for medical devices from public hospitals to increase demand
    • 10.4.5 SPAIN
      • 10.4.5.1 Increasing investments in healthcare infrastructure to propel market
    • 10.4.6 REST OF EUROPE
  • 10.5 MIDDLE EAST & AFRICA
    • 10.5.1 GCC COUNTRIES
      • 10.5.1.1 Saudi Arabia
        • 10.5.1.1.1 Need for advanced medical technologies to drive market
      • 10.5.1.2 Rest of GCC countries
    • 10.5.2 SOUTH AFRICA
      • 10.5.2.1 Outbreak of contagious diseases to drive market
    • 10.5.3 REST OF MIDDLE EAST & AFRICA
  • 10.6 SOUTH AMERICA
    • 10.6.1 BRAZIL
      • 10.6.1.1 Largest market for medical elastomers in South America
    • 10.6.2 ARGENTINA
      • 10.6.2.1 Growing demand for medical devices to drive market
    • 10.6.3 REST OF SOUTH AMERICA

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2019-2024
  • 11.3 REVENUE ANALYSIS, 2021-2023
  • 11.4 MARKET SHARE ANALYSIS, 2023
    • 11.4.1 NORTH AMERICA: MARKET SHARE ANALYSIS, BY APPLICATION, 2023
    • 11.4.2 EUROPE: MARKET SHARE ANALYSIS, BY APPLICATION, 2023
    • 11.4.3 ASIA PACIFIC: MARKET SHARE ANALYSIS, BY APPLICATION, 2023
    • 11.4.4 DOW
    • 11.4.5 EXXON MOBIL CORPORATION
    • 11.4.6 CELANESE CORPORATION
    • 11.4.7 BASF
    • 11.4.8 WACKER CHEMIE AG
  • 11.5 COMPANY VALUATION AND FINANCIAL METRICS
  • 11.6 BRAND/PRODUCT COMPARISON
    • 11.6.1 MEDICAL ELASTOMERS MARKET: BRAND/PRODUCT COMPARISON ANALYSIS
    • 11.6.2 ELASTOLLAN
    • 11.6.3 ENGAGE 8480K HEALTH+
    • 11.6.4 HYTREL
    • 11.6.5 ECDEL
  • 11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 11.7.1 STARS
    • 11.7.2 EMERGING LEADERS
    • 11.7.3 PERVASIVE PLAYERS
    • 11.7.4 PARTICIPANTS
    • 11.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 11.7.5.1 Overall company footprint
      • 11.7.5.2 Region footprint
      • 11.7.5.3 Technology footprint
      • 11.7.5.4 Type Footprint
      • 11.7.5.5 Application footprint
      • 11.7.5.6 Industry footprint
  • 11.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 11.8.1 PROGRESSIVE COMPANIES
    • 11.8.2 RESPONSIVE COMPANIES
    • 11.8.3 DYNAMIC COMPANIES
    • 11.8.4 STARTING BLOCKS
    • 11.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
      • 11.8.5.1 Detailed list of startups/SMEs
      • 11.8.5.2 Competitive benchmarking of startups/SMEs
  • 11.9 COMPETITIVE SCENARIO
    • 11.9.1 PRODUCT LAUNCHES
    • 11.9.2 DEALS
    • 11.9.3 EXPANSIONS
    • 11.9.4 OTHER DEVELOPMENTS

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
    • 12.1.1 DOW
      • 12.1.1.1 Business overview
      • 12.1.1.2 Products offered
      • 12.1.1.3 Recent developments
        • 12.1.1.3.1 Other developments
      • 12.1.1.4 MnM view
        • 12.1.1.4.1 Key strengths
        • 12.1.1.4.2 Strategic choices
        • 12.1.1.4.3 Weaknesses and competitive threats
    • 12.1.2 EXXON MOBIL CORPORATION
      • 12.1.2.1 Business overview
      • 12.1.2.2 Products offered
      • 12.1.2.3 MnM view
        • 12.1.2.3.1 Key strengths
        • 12.1.2.3.2 Strategic choices
        • 12.1.2.3.3 Weaknesses and competitive threats
    • 12.1.3 CELANESE CORPORATION
      • 12.1.3.1 Business overview
      • 12.1.3.2 Products offered
      • 12.1.3.3 Recent developments
        • 12.1.3.3.1 Deals
      • 12.1.3.4 MnM view
        • 12.1.3.4.1 Key strengths
        • 12.1.3.4.2 Strategic choices
        • 12.1.3.4.3 Weaknesses and competitive threats
    • 12.1.4 BASF
      • 12.1.4.1 Business overview
      • 12.1.4.2 Products offered
      • 12.1.4.3 Recent developments
        • 12.1.4.3.1 Expansions
      • 12.1.4.4 MnM view
        • 12.1.4.4.1 Key strengths
        • 12.1.4.4.2 Strategic choices
        • 12.1.4.4.3 Weaknesses and competitive threats
    • 12.1.5 WACKER CHEMIE AG
      • 12.1.5.1 Business overview
      • 12.1.5.2 Products offered
      • 12.1.5.3 Recent developments
        • 12.1.5.3.1 Product launches
        • 12.1.5.3.2 Expansions
      • 12.1.5.4 MnM view
        • 12.1.5.4.1 Key strengths
        • 12.1.5.4.2 Strategic choices
        • 12.1.5.4.3 Weaknesses and competitive threats
    • 12.1.6 EASTMAN CHEMICAL COMPANY
      • 12.1.6.1 Business overview
      • 12.1.6.2 Products offered
      • 12.1.6.3 MnM view
        • 12.1.6.3.1 Key strengths
        • 12.1.6.3.2 Strategic choices
        • 12.1.6.3.3 Weaknesses and competitive threats
    • 12.1.7 SYENSQO
      • 12.1.7.1 Business overview
      • 12.1.7.2 Products offered
      • 12.1.7.3 Recent developments
        • 12.1.7.3.1 Other developments
      • 12.1.7.4 MnM view
        • 12.1.7.4.1 Key strengths
        • 12.1.7.4.2 Strategic choices
        • 12.1.7.4.3 Weaknesses and competitive threats
    • 12.1.8 KURARAY CO., LTD
      • 12.1.8.1 Business overview
      • 12.1.8.2 Products offered
      • 12.1.8.3 MnM view
        • 12.1.8.3.1 Key strengths
        • 12.1.8.3.2 Strategic choices
        • 12.1.8.3.3 Weaknesses and competitive threats
    • 12.1.9 MITSUBISHI CHEMICAL GROUP CORPORATION
      • 12.1.9.1 Business overview
      • 12.1.9.2 Products offered
      • 12.1.9.3 Recent developments
        • 12.1.9.3.1 Other developments
        • 12.1.9.3.2 Deals
      • 12.1.9.4 MnM view
    • 12.1.10 MOMENTIVE PERFORMANCE MATERIALS
      • 12.1.10.1 Business overview
      • 12.1.10.2 Products offered
      • 12.1.10.3 MnM view
    • 12.1.11 ENVALIOR
      • 12.1.11.1 Business overview
      • 12.1.11.2 Products offered
    • 12.1.12 ZEON CORPORATION
      • 12.1.12.1 Business overview
      • 12.1.12.2 Products offered
    • 12.1.13 THE LUBRIZOL CORPORATION
      • 12.1.13.1 Business overview
      • 12.1.13.2 Products offered
      • 12.1.13.3 MnM view
  • 12.2 OTHER PLAYERS
    • 12.2.1 KRATON CORPORATION
    • 12.2.2 FOSTER CORPORATION
    • 12.2.3 BIOMERICS
    • 12.2.4 RTP COMPANY
    • 12.2.5 ROMAR ENGINEERING
    • 12.2.6 THE RUBBER GROUP
    • 12.2.7 KENT ELASTOMER PRODUCTS
    • 12.2.8 RAUMEDIC AG
    • 12.2.9 THE HYGENIC COMPANY, LLC
    • 12.2.10 HEXAPOL AB
    • 12.2.11 TEKNI-PLEX, INC
    • 12.2.12 TRINSEO
    • 12.2.13 TRELLEBORG AB
    • 12.2.14 SAINT-GOBAIN

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 US: CONSUMER MEDICAL DEVICES SALES, 2021-2023 (USD MILLION)
  • TABLE 2 MEDICAL ELASTOMERS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 3 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP-THREE END- USE INDUSTRIES
  • TABLE 4 KEY BUYING CRITERIA FOR TOP-THREE END-USE INDUSTRIES
  • TABLE 5 PROJECTED REAL GDP GROWTH (ANNUAL PERCENTAGE CHANGE) OF KEY COUNTRIES, 2019-2023
  • TABLE 6 GDP ANNUAL PERCENTAGE CHANGE AND PROJECTION OF KEY COUNTRIES, 2024-2029
  • TABLE 7 HEALTH EXPENDITURE AS PERCENTAGE OF GDP, 2019-2022
  • TABLE 8 MEDICAL ELASTOMERS MARKET: ROLE OF PLAYERS IN ECOSYSTEM
  • TABLE 9 MEDICAL ELASTOMERS MARKET: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 10 IMPORT DATA FOR HS CODE 391000-COMPLIANT PRODUCTS, BY COUNTRY, 2019-2023 (USD THOUSAND)
  • TABLE 11 EXPORT DATA FOR HS CODE 391000-COMPLIANT PRODUCTS, BY COUNTRY, 2019-2023 (USD THOUSAND)
  • TABLE 12 IMPORT DATA FOR HS CODE 400270-COMPLIANT PRODUCTS, BY COUNTRY, 2019-2023 (USD THOUSAND)
  • TABLE 13 EXPORT DATA FOR HS CODE 400270-COMPLIANT PRODUCTS, BY COUNTRY, 2019-2023 (USD THOUSAND)
  • TABLE 14 MEDICAL ELASTOMERS MARKET: KEY CONFERENCES AND EVENTS, 2024-2025
  • TABLE 15 LIST OF PATENTS, 2024
  • TABLE 16 LIST OF POTENTIAL CUSTOMERS
  • TABLE 17 MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2021-2023 (KILOTON)
  • TABLE 18 MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2024-2029 (KILOTON)
  • TABLE 19 MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2021-2023 (USD MILLION)
  • TABLE 20 MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2024-2029 (USD MILLION)
  • TABLE 21 MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021-2023 (KILOTON)
  • TABLE 22 MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024-2029 (KILOTON)
  • TABLE 23 MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 24 MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 25 MEDICAL ELASTOMERS MARKET, BY TYPE, 2021-2023 (KILOTON)
  • TABLE 26 MEDICAL ELASTOMERS MARKET, BY TYPE, 2024-2029 (KILOTON)
  • TABLE 27 MEDICAL ELASTOMERS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 28 MEDICAL ELASTOMERS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 29 MEDICAL ELASTOMERS MARKET, BY REGION, 2021-2023 (KILOTON)
  • TABLE 30 MEDICAL ELASTOMERS MARKET, BY REGION, 2024-2029 (KILOTON)
  • TABLE 31 MEDICAL ELASTOMERS MARKET, BY REGION, 2021-2023 (USD MILLION)
  • TABLE 32 MEDICAL ELASTOMERS MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 33 NORTH AMERICA: MARKET SHARES OF DIFFERENT TYPES OF MEDICAL ELASTOMERS, BY APPLICATION, 2023
  • TABLE 34 NORTH AMERICA: MEDICAL ELASTOMERS MARKET, BY COUNTRY, 2021-2023 (KILOTON)
  • TABLE 35 NORTH AMERICA: MEDICAL ELASTOMERS MARKET, BY COUNTRY, 2024-2029 (KILOTON)
  • TABLE 36 NORTH AMERICA: MEDICAL ELASTOMERS MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 37 NORTH AMERICA: MEDICAL ELASTOMERS MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 38 NORTH AMERICA: MEDICAL ELASTOMERS MARKET, BY TYPE, 2021-2023 (KILOTON)
  • TABLE 39 NORTH AMERICA: MEDICAL ELASTOMERS MARKET, BY TYPE, 2024-2029 (KILOTON)
  • TABLE 40 NORTH AMERICA: MEDICAL ELASTOMERS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 41 NORTH AMERICA: MEDICAL ELASTOMERS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 42 NORTH AMERICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021-2023 (KILOTON)
  • TABLE 43 NORTH AMERICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024-2029 (KILOTON)
  • TABLE 44 NORTH AMERICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 45 NORTH AMERICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 46 NORTH AMERICA: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2021-2023 (KILOTON)
  • TABLE 47 NORTH AMERICA: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2024-2029 (KILOTON)
  • TABLE 48 NORTH AMERICA: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2021-2023 (USD MILLION)
  • TABLE 49 NORTH AMERICA: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2024-2029 (USD MILLION)
  • TABLE 50 US: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021-2023 (KILOTON)
  • TABLE 51 US: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024-2029 (KILOTON)
  • TABLE 52 US: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 53 US: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 54 CANADA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021-2023 (KILOTON)
  • TABLE 55 CANADA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024-2029 (KILOTON)
  • TABLE 56 CANADA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 57 CANADA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 58 MEXICO: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021-2023 (KILOTON)
  • TABLE 59 MEXICO: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024-2029 (KILOTON)
  • TABLE 60 MEXICO: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 61 MEXICO: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 62 ASIA PACIFIC: MARKET SHARES OF DIFFERENT TYPES OF MEDICAL ELASTOMERS, BY APPLICATION, 2023
  • TABLE 63 ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY COUNTRY, 2021-2023 (KILOTON)
  • TABLE 64 ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY COUNTRY, 2024-2029 (KILOTON)
  • TABLE 65 ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 66 ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 67 ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY TYPE, 2021-2023 (KILOTON)
  • TABLE 68 ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY TYPE, 2024-2029 (KILOTON)
  • TABLE 69 ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 70 ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 71 ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021-2023 (KILOTON)
  • TABLE 72 ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024-2029 (KILOTON)
  • TABLE 73 ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 74 ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 75 ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2021-2023 (KILOTON)
  • TABLE 76 ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2024-2029 (KILOTON)
  • TABLE 77 ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2021-2023 (USD MILLION)
  • TABLE 78 ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2024-2029 (USD MILLION)
  • TABLE 79 CHINA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021-2023 (KILOTON)
  • TABLE 80 CHINA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024-2029 (KILOTON)
  • TABLE 81 CHINA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 82 CHINA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 83 JAPAN: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021-2023 (KILOTON)
  • TABLE 84 JAPAN: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024-2029 (KILOTON)
  • TABLE 85 JAPAN: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 86 JAPAN: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 87 INDIA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021-2023 (KILOTON)
  • TABLE 88 INDIA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024-2029 (KILOTON)
  • TABLE 89 INDIA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 90 INDIA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 91 SOUTH KOREA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021-2023 (KILOTON)
  • TABLE 92 SOUTH KOREA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024-2029 (KILOTON)
  • TABLE 93 SOUTH KOREA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 94 SOUTH KOREA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 95 INDONESIA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021-2023 (KILOTON)
  • TABLE 96 INDONESIA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024-2029 (KILOTON)
  • TABLE 97 INDONESIA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 98 INDONESIA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 99 REST OF ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021-2023 (KILOTON)
  • TABLE 100 REST OF ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024-2029 (KILOTON)
  • TABLE 101 REST OF ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 102 REST OF ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 103 EUROPE: MARKET SHARES OF DIFFERENT TYPES OF MEDICAL ELASTOMERS, BY APPLICATION, 2023
  • TABLE 104 EUROPE: MEDICAL ELASTOMERS MARKET, BY COUNTRY, 2021-2023 (KILOTON)
  • TABLE 105 EUROPE: MEDICAL ELASTOMERS MARKET, BY COUNTRY, 2024-2029 (KILOTON)
  • TABLE 106 EUROPE: MEDICAL ELASTOMERS MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 107 EUROPE: MEDICAL ELASTOMERS MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 108 EUROPE: MEDICAL ELASTOMERS MARKET, BY TYPE, 2021-2023 (KILOTON)
  • TABLE 109 EUROPE: MEDICAL ELASTOMERS MARKET, BY TYPE, 2024-2029 (KILOTON)
  • TABLE 110 EUROPE: MEDICAL ELASTOMERS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 111 EUROPE: MEDICAL ELASTOMERS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 112 EUROPE: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021-2023 (KILOTON)
  • TABLE 113 EUROPE: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024-2029 (KILOTON)
  • TABLE 114 EUROPE: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 115 EUROPE: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 116 EUROPE: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2021-2023 (KILOTON)
  • TABLE 117 EUROPE: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2024-2029 (KILOTON)
  • TABLE 118 EUROPE: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2021-2023 (USD MILLION)
  • TABLE 119 EUROPE: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2024-2029 (USD MILLION)
  • TABLE 120 GERMANY: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021-2023 (KILOTON)
  • TABLE 121 GERMANY: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024-2029 (KILOTON)
  • TABLE 122 GERMANY: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 123 GERMANY: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 124 UK: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021-2023 (KILOTON)
  • TABLE 125 UK: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024-2029 (KILOTON)
  • TABLE 126 UK: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 127 UK: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 128 FRANCE: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021-2023 (KILOTON)
  • TABLE 129 FRANCE: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024-2029 (KILOTON)
  • TABLE 130 FRANCE: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 131 FRANCE: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 132 ITALY: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021-2023 (KILOTON)
  • TABLE 133 ITALY: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024-2029 (KILOTON)
  • TABLE 134 ITALY: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 135 ITALY: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 136 SPAIN: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021-2023 (KILOTON)
  • TABLE 137 SPAIN: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024-2029 (KILOTON)
  • TABLE 138 SPAIN: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 139 SPAIN: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 140 REST OF EUROPE: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021-2023 (KILOTON)
  • TABLE 141 REST OF EUROPE: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024-2029 (KILOTON)
  • TABLE 142 REST OF EUROPE: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 143 REST OF EUROPE: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 144 MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET, BY COUNTRY, 2021-2023 (KILOTON)
  • TABLE 145 MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET, BY COUNTRY, 2024-2029 (KILOTON)
  • TABLE 146 MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 147 MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 148 MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET, BY TYPE, 2021-2023 (KILOTON)
  • TABLE 149 MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET, BY TYPE, 2024-2029 (KILOTON)
  • TABLE 150 MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 151 MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 152 MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021-2023 (KILOTON)
  • TABLE 153 MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024-2029 (KILOTON)
  • TABLE 154 MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 155 MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 156 MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2021-2023 (KILOTON)
  • TABLE 157 MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2024-2029 (KILOTON)
  • TABLE 158 MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2021-2023 (USD MILLION)
  • TABLE 159 MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2024-2029 (USD MILLION)
  • TABLE 160 SAUDI ARABIA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021-2023 (KILOTON)
  • TABLE 161 SAUDI ARABIA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024-2029 (KILOTON)
  • TABLE 162 SAUDI ARABIA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 163 SAUDI ARABIA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 164 REST OF GCC COUNTRIES: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021-2023 (KILOTON)
  • TABLE 165 REST OF GCC COUNTRIES: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024-2029 (KILOTON)
  • TABLE 166 REST OF GCC COUNTRIES: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 167 REST OF GCC COUNTRIES: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 168 SOUTH AFRICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021-2023 (KILOTON)
  • TABLE 169 SOUTH AFRICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024-2029 (KILOTON)
  • TABLE 170 SOUTH AFRICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 171 SOUTH AFRICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 172 REST OF MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021-2023 (KILOTON)
  • TABLE 173 REST OF MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024-2029 (KILOTON)
  • TABLE 174 REST OF MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 175 REST OF MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 176 SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY COUNTRY, 2021-2023 (KILOTON)
  • TABLE 177 SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY COUNTRY, 2024-2029 (KILOTON)
  • TABLE 178 SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 179 SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 180 SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY TYPE, 2021-2023 (KILOTON)
  • TABLE 181 SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY TYPE, 2024-2029 (KILOTON)
  • TABLE 182 SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY TYPE, 2021-2023 (USD MILLION)
  • TABLE 183 SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 184 SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021-2023 (KILOTON)
  • TABLE 185 SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024-2029 (KILOTON)
  • TABLE 186 SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 187 SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 188 SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2021-2023 (KILOTON)
  • TABLE 189 SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2024-2029 (KILOTON)
  • TABLE 190 SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2021-2023 (USD MILLION)
  • TABLE 191 SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2024-2029 (USD MILLION)
  • TABLE 192 BRAZIL: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021-2023 (KILOTON)
  • TABLE 193 BRAZIL: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024-2029 (KILOTON)
  • TABLE 194 BRAZIL: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 195 BRAZIL: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 196 ARGENTINA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021-2023 (KILOTON)
  • TABLE 197 ARGENTINA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024-2029 (KILOTON)
  • TABLE 198 ARGENTINA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 199 ARGENTINA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 200 REST OF SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021-2023 (KILOTON)
  • TABLE 201 REST OF SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024-2029 (KILOTON)
  • TABLE 202 REST OF SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 203 REST OF SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 204 MEDICAL ELASTOMERS MARKET: DEGREE OF COMPETITION
  • TABLE 205 NORTH AMERICA: MARKET SHARE ANALYSIS, BY MEDICAL TUBING, 2023
  • TABLE 206 NORTH AMERICA: MARKET SHARE ANALYSIS, BY CATHETER, 2023
  • TABLE 207 NORTH AMERICA: MARKET SHARE ANALYSIS, BY SYRINGE, 2023
  • TABLE 208 EUROPE: MARKET SHARE ANALYSIS, BY MEDICAL TUBING, 2023
  • TABLE 209 EUROPE: MARKET SHARE ANALYSIS, BY CATHETER, 2023
  • TABLE 210 EUROPE: MARKET SHARE ANALYSIS, BY SYRINGE, 2023
  • TABLE 211 ASIA PACIFIC: MARKET SHARE ANALYSIS, BY MEDICAL TUBING, 2023
  • TABLE 212 ASIA PACIFIC: MARKET SHARE ANALYSIS, BY CATHETER, 2023
  • TABLE 213 ASIA PACIFIC: MARKET SHARE ANALYSIS, BY SYRINGE, 2023
  • TABLE 214 MEDICAL ELASTOMERS MARKET: REGION FOOTPRINT
  • TABLE 215 MEDICAL ELASTOMERS MARKET: TECHNOLOGY FOOTPRINT
  • TABLE 216 MEDICAL ELASTOMERS MARKET: TYPE FOOTPRINT
  • TABLE 217 MEDICAL ELASTOMERS MARKET: APPLICATION FOOTPRINT
  • TABLE 218 MEDICAL ELASTOMERS MARKET: INDUSTRY FOOTPRINT
  • TABLE 219 MEDICAL ELASTOMERS MARKET: KEY STARTUPS/SMES
  • TABLE 220 MEDICAL ELASTOMERS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
  • TABLE 221 MEDICAL ELASTOMERS MARKET: PRODUCT LAUNCHES, JANUARY 2019-NOVEMBER 2024
  • TABLE 222 MEDICAL ELASTOMERS MARKET: DEALS, JANUARY 2019-NOVEMBER 2024
  • TABLE 223 MEDICAL ELASTOMERS MARKET: EXPANSIONS, JANUARY 2019-NOVEMBER 2024
  • TABLE 224 MEDICAL ELASTOMERS MARKET: OTHER DEVELOPMENTS, JANUARY 2019- NOVEMBER 2024
  • TABLE 225 DOW: COMPANY OVERVIEW
  • TABLE 226 DOW.: PRODUCTS OFFERED
  • TABLE 227 DOW: OTHER DEVELOPMENTS, JANUARY 2019-NOVEMBER 2024
  • TABLE 228 EXXON MOBIL CORPORATION: COMPANY OVERVIEW
  • TABLE 229 EXXON MOBIL CORPORATION: PRODUCT OFFERINGS
  • TABLE 230 CELANESE CORPORATION: COMPANY OVERVIEW
  • TABLE 231 CELANESE CORPORATION: PRODUCTS OFFERED
  • TABLE 232 CELANESE CORPORATION: DEALS, JANUARY 2019-NOVEMBER 2024
  • TABLE 233 BASF: COMPANY OVERVIEW
  • TABLE 234 BASF: PRODUCTS OFFERED
  • TABLE 235 BASF: EXPANSIONS, JANUARY 2019-NOVEMBER 2024
  • TABLE 236 WACKER CHEMIE AG: COMPANY OVERVIEW
  • TABLE 237 WACKER CHEMIE AG: PRODUCTS OFFERED
  • TABLE 238 WACKER CHEMIE AG: PRODUCT LAUNCHES, JANUARY 2019-NOVEMBER 2024
  • TABLE 239 WACKER CHEMIE AG: EXPANSIONS, JANUARY 2019-NOVEMBER 2024
  • TABLE 240 EASTMAN CHEMICAL COMPANY: COMPANY OVERVIEW
  • TABLE 241 EASTMAN CHEMICAL COMPANY: PRODUCTS OFFERED
  • TABLE 242 SYENSQO: COMPANY OVERVIEW
  • TABLE 243 SYENSQO: PRODUCTS OFFERED
  • TABLE 244 SYENSQO: OTHER DEVELOPMENTS, JANUARY 2019-NOVEMBER 2024
  • TABLE 245 KURARAY CO., LTD: COMPANY OVERVIEW
  • TABLE 246 KURARAY CO., LTD: PRODUCT OFFERINGS
  • TABLE 247 MITSUBISHI CHEMICAL GROUP CORPORATION: COMPANY OVERVIEW
  • TABLE 248 MITSUBISHI CHEMICAL GROUP CORPORATION: PRODUCTS OFFERED
  • TABLE 249 MITSUBISHI CHEMICAL GROUP CORPORATION: OTHER DEVELOPMENTS, JANUARY 2019-NOVEMBER 2024
  • TABLE 250 MITSUBISHI CHEMICAL GROUP CORPORATION: DEALS, JANUARY 2019- NOVEMBER 2024
  • TABLE 251 MOMENTIVE PERFORMANCE MATERIALS: COMPANY OVERVIEW
  • TABLE 252 MOMENTIVE PERFORMANCE MATERIALS: PRODUCTS OFFERED
  • TABLE 253 ENVALIOR: COMPANY OVERVIEW
  • TABLE 254 ENVALIOR: PRODUCTS OFFERED
  • TABLE 255 ZEON CORPORATION: COMPANY OVERVIEW
  • TABLE 256 ZEON CORPORATION: PRODUCTS OFFERED
  • TABLE 257 THE LUBRIZOL CORPORATION: COMPANY OVERVIEW
  • TABLE 258 THE LUBRIZOL CORPORATION: PRODUCTS OFFERED
  • TABLE 259 KRATON CORPORATION: COMPANY OVERVIEW
  • TABLE 260 FOSTER CORPORATION: COMPANY OVERVIEW
  • TABLE 261 BIOMERICS: COMPANY OVERVIEW
  • TABLE 262 RTP COMPANY: COMPANY OVERVIEW
  • TABLE 263 ROMAR ENGINEERING: COMPANY OVERVIEW
  • TABLE 264 THE RUBBER GROUP: COMPANY OVERVIEW
  • TABLE 265 KENT ELASTOMER PRODUCTS: COMPANY OVERVIEW
  • TABLE 266 RAUMEDIC AG: COMPANY OVERVIEW
  • TABLE 267 THE HYGENIC COMPANY, LLC: COMPANY OVERVIEW
  • TABLE 268 HEXAPOL AB: COMPANY OVERVIEW
  • TABLE 269 TEKNI-PLEX, INC: COMPANY OVERVIEW
  • TABLE 270 TRINSEO: COMPANY OVERVIEW
  • TABLE 271 TRELLEBORG AB: COMPANY OVERVIEW
  • TABLE 272 SAINT-GOBAIN: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 MEDICAL ELASTOMERS MARKET SEGMENTATION AND REGIONAL SCOPE
  • FIGURE 2 MEDICAL ELASTOMERS MARKET: RESEARCH DESIGN
  • FIGURE 3 MEDICAL ELASTOMERS MARKET: BOTTOM-UP APPROACH
  • FIGURE 4 MEDICAL ELASTOMERS MARKET: TOP-DOWN APPROACH
  • FIGURE 5 MARKET SIZE ESTIMATION: MEDICAL ELASTOMERS MARKET (TOP-DOWN APPROACH)
  • FIGURE 6 DEMAND-SIDE FORECAST PROJECTIONS: DRIVERS
  • FIGURE 7 MEDICAL ELASTOMERS MARKET: DATA TRIANGULATION
  • FIGURE 8 THERMOSET ELASTOMERS TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 9 MEDICAL TUBING APPLICATION TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 10 HOSPITALS & CLINICS TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 11 ASIA PACIFIC TO BE FASTEST-GROWING REGION DURING FORECAST PERIOD
  • FIGURE 12 GROWING DEMAND FOR MEDICAL DEVICES FROM HEALTHCARE SECTOR TO DRIVE MARKET
  • FIGURE 13 THERMOPLASTIC ELASTOMERS TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 14 IMPLANTS SEGMENT TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 15 HOSPITALS & CLINICS TO BE LARGEST END-USE INDUSTRY FOR MEDICAL ELASTOMERS
  • FIGURE 16 INDIA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN MEDICAL ELASTOMERS MARKET
  • FIGURE 18 MEDICAL ELASTOMERS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END-USE INDUSTRIES
  • FIGURE 20 KEY BUYING CRITERIA FOR TOP-THREE END-USE INDUSTRIES
  • FIGURE 22 MEDICAL ELASTOMERS MARKET: ECOSYSTEM
  • FIGURE 23 MEDICAL ELASTOMERS MARKET: TRENDS AND DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • FIGURE 24 IMPORT DATA FOR HS-CODE 391000-COMPLIANT PRODUCTS, BY COUNTRY 2019-2023 (USD THOUSAND)
  • FIGURE 25 EXPORT DATA FOR HS-CODE 391000-COMPLIANT PRODUCTS, BY COUNTRY 2019-2023 (USD THOUSAND)
  • FIGURE 26 IMPORT DATA FOR HS-CODE 400270-COMPLIANT PRODUCTS, BY COUNTRY 2019-2023 (USD THOUSAND)
  • FIGURE 27 EXPORT DATA FOR HS CODE 400270-COMPLIANT PRODUCTS, BY COUNTRY 2019-2023 (USD THOUSAND)
  • FIGURE 28 AVERAGE SELLING PRICE TREND OF MEDICAL ELASTOMERS, BY REGION (USD/KG), 2021-2023
  • FIGURE 29 AVERAGE SELLING PRICE TREND OF MEDICAL ELASTOMERS, BY APPLICATION (USD/KG), 2021-2023
  • FIGURE 30 AVERAGE SELLING PRICE TREND OF MEDICAL ELASTOMERS, BY END-USE INDUSTRY (USD/KG), 2021-2023
  • FIGURE 31 INVESTMENT AND FUNDING SCENARIO, 2021-2023 (USD MILLION)
  • FIGURE 32 PATENTS APPLIED AND GRANTED, 2014-2023
  • FIGURE 33 LEGAL STATUS OF PATENTS (2013-2024)
  • FIGURE 34 TOP JURISDICTIONS
  • FIGURE 35 HOSPITALS & CLINICS SEGMENT TO BE LARGEST END-USE INDUSTRY DURING FORECAST PERIOD
  • FIGURE 36 MEDICAL TUBING TO BE LARGEST APPLICATION SEGMENT DURING FORECAST PERIOD
  • FIGURE 37 THERMOSET ELASTOMERS TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 38 ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 39 NORTH AMERICA: MEDICAL ELASTOMERS MARKET SNAPSHOT
  • FIGURE 40 ASIA PACIFIC: MEDICAL ELASTOMERS MARKET SNAPSHOT
  • FIGURE 41 EUROPE: MEDICAL ELASTOMERS MARKET SNAPSHOT
  • FIGURE 42 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MEDICAL ELASTOMERS MARKET BETWEEN JANUARY 2019 AND NOVEMBER 2024
  • FIGURE 43 REVENUE ANALYSIS OF KEY PLAYERS IN MEDICAL ELASTOMERS MARKET, 2021-2023
  • FIGURE 44 MEDICAL ELASTOMERS MARKET SHARE OF KEY PLAYERS, 2023
  • FIGURE 45 VALUATION OF LEADING COMPANIES IN MEDICAL ELASTOMERS MARKET, 2023
  • FIGURE 46 FINANCIAL METRICS OF LEADING COMPANIES IN MEDICAL ELASTOMERS MARKET, 2023
  • FIGURE 47 MEDICAL ELASTOMERS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 48 MEDICAL ELASTOMERS MARKET: OVERALL COMPANY FOOTPRINT
  • FIGURE 49 MEDICAL ELASTOMERS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 50 DOW: COMPANY SNAPSHOT
  • FIGURE 51 EXXON MOBIL CORPORATION: COMPANY SNAPSHOT
  • FIGURE 52 CELANESE CORPORATION: COMPANY SNAPSHOT
  • FIGURE 53 BASF: COMPANY SNAPSHOT
  • FIGURE 54 WACKER CHEMIE AG: COMPANY SNAPSHOT
  • FIGURE 55 EASTMAN CHEMICAL COMPANY: COMPANY SNAPSHOT
  • FIGURE 56 SYENSQO: COMPANY SNAPSHOT
  • FIGURE 57 KURARAY CO., LTD: COMPANY SNAPSHOT
  • FIGURE 58 MITSUBISHI CHEMICAL GROUP CORPORATION: COMPANY SNAPSHOT
  • FIGURE 59 ZEON CORPORATION: COMPANY SNAPSHOT